Adir Et Compagnie

Science Union Et Cie

Science Union Et Cie, Societe Francaise De Recherche Medicale

Adir

Adir, S.a.r.l.

Les Laboratoires Servier

Science Union Et Cie, Societe Francaise De Recherche Medical

Jacques Duhault

Gilbert Regnier

Michelle Boulanger

Pierre Hugon

Laszlo Beregi

Denis Ravel

Michel Laubie

Alain Dhainaut

Jean Albert Boutin

Joseph Espinal

Guillaume De Nanteuil

Claude Guillonneau

Jean-Michel Lacoste

Yolande Herve

Daniel-Henri Caignard

Michel Wierzbicki

Yves Charton

Jean-Luc Fauchere

Jean-Claude Ortuno

Nigel Levens

Ignacio Aldana Moraza

Francoise Lacour

Odile Dellazuana

Antonio Monge Vega

Francois Roman

Georges Remond

Michel Vincent

Charles E Malen

Alex Cordi

Elisabeth Mocaer

David Billington

Isabelle Picard

Annie Kamoun

Michelle Boullanger

Gilbert Reginier

Aminotriazole compounds

Hydrazide compounds

The compounds are 5-(4-substituted benzyl)thiazolidine-2,4-diones, enantiomers, diastereoisomers and pharmaceutically tolerable salts thereof, useful for treating conditions of insulin-resistance and/or non insulin-dependent diabetes. A compound disclosed is: .(R,S)-5-{4-[2-benzofuran-2-yl)carbonylamino)ethyl]benzyl}thiazolidine-2,4 -dione.

Thiazolidinedione compounds

The compounds are 5-(4-substituted benzyl)thiazolidine-2,4-diones, enantiomers, diastereoisomers and pharmaceutically tolerable salts thereof, useful for treating conditions of insulin-resistance and/or non insulin-dependent diabetes. A compound disclosed is: 5-{4-[2-(2-methoxy-5-chlorobenzamido)ethyl]benzyl}thiazolidine-2,4-dione.

Thazolidinedione compounds

A compound selected from those of formula (I): ##STR1## wherein: R.sub.1, R'.sub.1 and R.sub.2 are each selected, independently of the others, from hydrogen and an alkyl radical, the two R.sub.2 groups being in the cis position in relation to the rings,

Naphthalene compounds

Compounds of formula (I): ##STR1## in which: R.sub.1 and R.sub.2, which are identical or different, represent a higher alkyl or higher alkenyl radical,

Diacylglycerol nicotinates

Compounds of formula (I): ##STR1## in which: R represents any one of the groups defined in the description. Medicinal products.

2,4-thiazolidinedione compounds

Compounds of formula (I): ##STR1## in which: R represents any one of the groups defined in the description used as medicinal products.

Compounds of formula (I): ##STR1## in which: R.sub.1 or R.sub.4, which are identical or different, represent hydrogen or alkyl,

New vanadium complexes

The compounds are ethanolamine benzoate compounds useful for the treatment of syndrome X, and of hypertension in patients who are insulin resistant or have one or more metabolic anomalies. A compound disclosed is S-1-(m-trifluoromethylphenyl)-2-{.beta.-{4-[2-(N-(3,3-diphenylpropionyl)am ino)ethyl] benzoyloxy}ethylamino} propane.

Ethanolamine benzoate compounds

New ethanolamine benzoate compounds which can be used as medicaments and correspond to the formula: ##STR1## wherein R is as defined in the description, in the form of racemic compounds and enantiomers. These new compounds and their physiologically tolerable salts can be used therapeutically for treatment of insulin-resistance states.

Vanadium complexes

Growing community of inventors

Croissy sur Seine, France

Jacques Duhault